Search

everythinglearnresearchcommunity

for

Search:↓

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Ultrasonic microneedles improve hair regrowth treatment effectiveness without side effects.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Mutations in certain receptors can cause diseases and offer new treatment options.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Early balding at 40 increases prostate cancer risk.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.